Targeted Drug Delivery of Anticancer Agents Using C₅N₂ Substrate: Insights from Density Functional Theory

Cancer has a threatening impact on human health, and it is one of the primary causes of fatalities worldwide. Different conventional treatments have been employed to treat cancer, but their non-specific nature reduces their therapeutic efficacy. This study employs a C₅N₂-based targeted drug carrier to study the delivery mechanism of anticancer drugs, particularly cisplatin, carmustine, and mechlorethamine, using density functional theory (DFT). The geometries of the drugs, the C₅N₂ substrate, and the drug@C₅N₂ complexes were optimized at the PBE0-D3BJ/def2SVP level of theory. Interaction energy was computed for the complexes which follow the trend, i.e., cisplatin@C₅N₂ (−27.60 kcal mol⁻¹) > carmustine@C₅N₂ (−19.69 kcal mol⁻¹) > mechlorethamine@C₅N₂ (−17.79 kcal mol⁻¹). The non-covalent interaction (NCI) and quantum theory of atoms in molecules (QTAIM) analyses confirmed the presence of van der Waals forces between the carmustine@C₅N₂ and mechlorethamine@C₅N₂ complexes, while weak hydrogen bonding has also been observed between the cisplatin@C₅N₂ complex. Electron localization function (ELF) analysis was performed to analyze the degree of delocalization of electrons within the complexes. The electronic properties of the analytes and the C₅N₂ substrate confirmed the enhanced reactivity of the complexes and illustrated electron density shift between the drugs and the C₅N₂ sheet. Recovery time was determined to assess the biocompatibility and the desorption behavior of the drugs. Moreover, negative solvation energies and increased dipole moments in a solvent phase manifested enhanced solubility and easy circulation of the drugs in biological media. Subsequently, this study illustrates that cisplatin@C₅N₂, carmustine@C₅N₂, and mechlorethamine@C₅N₂ complexes can be utilized as efficient drug delivery systems.